Search

Your search keyword '"Kullberg, Bart-Jan"' showing total 1,128 results

Search Constraints

Start Over You searched for: Author "Kullberg, Bart-Jan" Remove constraint Author: "Kullberg, Bart-Jan" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,128 results on '"Kullberg, Bart-Jan"'

Search Results

1. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials

3. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

4. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

5. A comprehensive genetic map of cytokine responses in Lyme borreliosis

6. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

10. P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data

13. Towards personalized medicine: a scoping review of immunotherapy in sepsis.

14. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris

15. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

16. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications.

18. Correction to “Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study”

19. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

22. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

23. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

24. 231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis

25. Human TLR10 is an anti-inflammatory pattern-recognition receptor

26. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production

27. Identifying platelet-derived factors as amplifiers ofB. burgdorferi-induced cytokine production

30. Invasive candidiasis

32. Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital

36. Belangenverstrengeling bij wetenschappelijke advisering

39. Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia

40. Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study

41. Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12

43. Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources

45. Ocular Manifestations of Candidemia

Catalog

Books, media, physical & digital resources